Gao Wei and Kuang Peizhu of Haiwen & Partners review the key developments in China's capital markets in 2023, which included a seismic shift in regulation, and examine - with cautious optimism - the outlook for 2024
The U.S. released new regulations that will bring SPAC disclosure requirements more in line with traditional IPOs; First Chinese VC firm is included in U.S. Defense Department's military-related company list; and China is working on expanding its Anti-Money Laundering Law to cover virtual assets
Antitrust filing thresholds are raised. Jiangsu lists matters covered in the registration of intellectual property rights in data. The limit on a commercial property loan may not exceed 70% of the appraised value of the property.
In 2023, the healthcare industry in China was subject to significant legislative advancements and reforms aimed at addressing industry concerns and promoting innovation. Hanshuo Zhou and Xiaoyun Wang of Jingtian & Gongcheng summarize the key events, and provide a reflective review based on their' practical experience